Small decreases in total cholesterol ( 12.7 mg/dl ) and low-density lipoprotein ( LDL ) cholesterol ( 12.4 mg/dl ) were observed during the HCQ treatment periods ( both adjusted P < 0.05 compared to placebo ) .